Catalogo dei prodotti della ricerca

TURRIZIANI, Ombretta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.237
EU - Europa 2.576
AS - Asia 1.351
AF - Africa 56
SA - Sud America 47
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.151
IT - Italia 1.450
SG - Singapore 610
IN - India 296
CN - Cina 283
SE - Svezia 278
FI - Finlandia 191
UA - Ucraina 159
DE - Germania 102
IE - Irlanda 92
CA - Canada 73
ID - Indonesia 58
BG - Bulgaria 47
GB - Regno Unito 44
TG - Togo 39
RU - Federazione Russa 38
MY - Malesia 36
AR - Argentina 35
FR - Francia 31
NL - Olanda 28
RO - Romania 24
BE - Belgio 23
TR - Turchia 21
CH - Svizzera 13
MX - Messico 12
IR - Iran 9
BR - Brasile 8
GR - Grecia 7
HK - Hong Kong 7
KR - Corea 7
PL - Polonia 7
CZ - Repubblica Ceca 6
LV - Lettonia 6
AT - Austria 5
PT - Portogallo 5
SC - Seychelles 5
AU - Australia 4
IQ - Iraq 4
PH - Filippine 4
PK - Pakistan 4
ES - Italia 3
EU - Europa 3
JP - Giappone 3
KZ - Kazakistan 3
RS - Serbia 3
UG - Uganda 3
AL - Albania 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NO - Norvegia 2
PE - Perù 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
ZM - Zambia 2
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
KH - Cambogia 1
LT - Lituania 1
MA - Marocco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VA - Santa Sede (Città del Vaticano) 1
VN - Vietnam 1
Totale 10.275
Salva come PNG Salva come JPEG
Città #
Fairfield 981
Rome 596
Chandler 503
Singapore 471
Ashburn 447
Woodbridge 389
Houston 355
Seattle 349
Wilmington 317
Cambridge 299
Ann Arbor 237
Dearborn 195
Princeton 182
San Paolo di Civitate 177
Santa Clara 129
Lawrence 120
Plano 117
Dublin 90
Millbury 89
Beijing 88
Helsinki 84
Milan 73
New York 71
San Diego 70
Boston 68
Jacksonville 64
Fremont 57
Jakarta 57
Sofia 47
Andover 42
Ottawa 42
Boardman 40
Lomé 39
Federal 35
Toronto 26
Norwalk 25
Bremen 24
Brussels 23
Falls Church 22
Naples 22
Des Moines 20
Moscow 19
Nanjing 19
Dallas 18
Kunming 15
Hefei 14
Istanbul 13
Latina 13
Los Angeles 13
Mannheim 13
San Mateo 13
Bühl 12
Guangzhou 12
Hebei 11
Jinan 11
Paris 11
Falkenstein 9
Pesaro 9
Mexico City 8
Shanghai 8
Taurisano 8
Amsterdam 7
Ariccia 7
Florence 7
London 7
Bern 6
Brno 6
Hong Kong 6
Phoenix 6
Albano Laziale 5
Athens 5
Frankfurt am Main 5
Genoa 5
Indiana 5
Nanchang 5
Pomezia 5
Redwood City 5
Velletri 5
Vienna 5
Wuhan 5
Artena 4
Chicago 4
Cremona 4
Hyderabad 4
Lamezia Terme 4
Licenza 4
Mahé 4
Marseille 4
Modena 4
Mumbai 4
Munich 4
Okara 4
Perugia 4
Pune 4
Redmond 4
Sacramento 4
Seriate 4
Warsaw 4
Washington 4
Zhengzhou 4
Totale 7.518
Salva come PNG Salva come JPEG
Nome #
Infectious burden and atherosclerosis. A clinical issue 120
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis 119
TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE 118
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment 114
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease 113
Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial 111
Analysis of viral nucleic acids in duodenal biopsies from adult patients with active celiac disease: in search for an etiological relationship 111
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition 108
CMV load quantitation by the automated VERSANT k-PCR Molecular System in plasma of transplanted patients 107
Toll-like receptor 4-dependent platelet-related thrombosis in SARS-CoV-2 infection 102
Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming 99
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 98
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy 98
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19) 97
Cellular issues relating to the resistance of HIV to antiretroviral agents 95
SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period 94
Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients 91
Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients 90
Molecular diagnosis of SARS-CoV-2 in seminal fluid 90
Expression of the mRNA Levels for MDR1, MRP1, MRP4, and MRP5 IN HIV Antiretroviral Naive Patients: Follow-up at 48 Weeks After the Beginning of Therapy 90
Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators 87
Early collection of saliva specimens from Bell's palsy patients: Quantitative analysis of HHV-6, HSV-1, and VZV 85
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients 85
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage regimen: 72-week follow-up 84
Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation 84
The synergistic effect of time of exposure, distance and no use of personal protective equipment in the determination of SARS-CoV-2 infection: Results of a contact tracing follow-up study in healthcareworkers 84
Is human immunodeficiency virus RNA load composed of neutralized immune complexes? 82
Short communication: analysis of the integrase gene from HIV type 1-positive patients living in a rural area of West Cameroon. 82
Study of the genotypic resistant pattern in HIV-infected women and children from rural west Cameroon 82
Anosmia and ageusia as predictive signs of COVID-19 in healthcare workers in Italy. A prospective case-control study 81
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection 80
May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors? 79
High HIV-1 diversity in immigrants resident in Italy (2008–2017) 79
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains 79
KI and WU polyomavirus in respiratory samples of sars‐cov‐2 infected patients 79
Consolidation of molecular testing in clinical virology 78
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient 78
Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients 78
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive? 78
IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection 77
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors 77
SARS-CoV-2 presence in seminal fluid: myth or reality 77
The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study) 77
MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients 76
RESISTANCE OF HIV-1 TO AZT MIGHT ALSO INVOLVE THE CELLULAR EXPRESSION OF MULTIDRUG RESISTANCE P-GLYCOPROTEIN 75
Copy-years viremia and risk of virological failure in long-term-treated HIV patients 75
Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients 74
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature 74
Cellular factors involved in the induction of resistance of HIV to antiretroviral agents. 73
Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome 72
Antiviral therapy: old and current issues. 72
Expression levels of TLRs involved in viral recognition in PBMCs from HIV-1-infected patients failing antiretroviral therapy 71
Sa1854 - Oral Bacteriotherapy Improves Gut Inflammation and Reduces Fecal Infectivity of HIV Subjects 71
null 70
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors 70
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 70
FURTHER STUDY OF THE MECHANISM UNDERLYING THE CELLULAR RESISTANCE TO AZT 69
null 69
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia 69
Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients 69
INTERFERON-INDUCED GENE EXPRESSION IN CERVICAL MUCOSA DURING HUMAN PAPILLOMAVIRUS INFECTION 68
Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab 68
Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab 68
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 67
Potential benefit of dolutegravir once daily: Efficacy and safety 67
In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine. 67
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 66
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2 66
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy. 66
Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy 66
Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia 66
A novel methodology for large-scale phylogeny partition 65
Cinetica di replicazione dell'HIV su C8166: aspetti biologici e applicativi 63
The effects of prolonged treatment with zidovudine, lamivudine and abacavir on a t- lymphoblastoid cell line 63
Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization 63
Analysis of the mRNA expression of DNA damage response genes in HIV infected patients 63
HIV-1 DIVERSITY AND ANTIRETROVIRAL RESISTANCE MUTATIONS AMONG TREATMENT NAÏVE PATIENTS FROM 2005-2017: A SINGLE CENTER EXPERIENCE 62
Comparative analysis of 2 commercial molecular tests for the detection of gastroenteric viruses on stool samples 62
Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients 61
Seroprevalence of group B Coxsackieviruses: retrospective study in an Italian population 61
Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2 61
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients 61
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 60
Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia 60
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b 60
Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection. 59
V3 Net Charge: Additional Tool in HIV-1 Tropism Prediction. 59
CORRELATION OF INTERFERON-INDUCED EXPRESSION OF MxA mRNA IN PERIPHERAL BLOOD MONONUCLEAR CELLS WITH THE RESPONSE OF PATIENTS WITH CHRONIC ACTIVE HEPATITIS C TO IFN-ALPHA THERAPY. 59
null 59
MONITORING OF DRUG RESISTANCE MUTATIONS IN PROVIRAL DNA OF PATIENTS RESPONDING TO ANTIRETROVIRAL THERAPY 58
null 58
Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection 57
Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis 57
null 57
TREATED HIV-1 PATIENTS WITH DIFFERENT LEVELS OF VIRAL SUPPRESSION: CHANGES IN MICRORNA EXPRESSION PROFILES 57
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study. 57
[Acquired immunodeficiency virus (HIV-1). Biological aspects and virological diagnosis]. 56
Non-steroidal anti-inflammatory drugs increase the antiretroviral activity of nucleoside reverse transcriptase inhibitors in HIV type-1-infected T-lymphocytes: role of multidrug resistance protein 4 56
Infectious agents in atherosclerotic cardiovascular diseases through oxidative stress 56
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 56
Totale 7.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.373 0 0 0 0 0 335 305 233 219 119 80 82
2020/2021991 92 84 43 62 66 87 77 90 132 151 74 33
2021/20221.981 49 111 144 119 205 74 66 209 208 127 362 307
2022/20232.062 366 459 127 200 212 192 34 139 163 42 88 40
2023/20241.237 91 129 62 105 114 166 34 119 14 157 124 122
2024/20251.163 111 157 221 203 181 290 0 0 0 0 0 0
Totale 10.754